Royal Devon and Exeter choose SonoSite's NanoMaxx(R) for haemodialysis services

The Royal Devon and Exeter NHS Foundation Trust has invested in four of SonoSite's NanoMaxx® handcarried ultrasound systems. End Quote

(1888PressRelease) March 02, 2012 - The Royal Devon and Exeter NHS Foundation Trust has invested in four of SonoSite's NanoMaxx® handcarried ultrasound systems for its central and satellite haemodialysis units. Rob Luke, matron for haemodialysis at Heavitree Hospital, Exeter, explained: "Once a fistula has been surgically created, the patient needs to have two needles inserted for dialysis. Before ultrasound, we had to locate the blood vessels manually relying on sensation, which can be difficult. About two years ago, we tried using an ultrasound probe to scan patient's arms prior to cannulation and found that this gave us a very good idea of the location of the blood vessels, their shape and depth, before we inserted the needles."

"The big advantage of the NanoMaxx is its simplicity and ease of use. It allows us to cannulate easily and effectively and get good flows early on. Where fistulas are difficult to access, we can also perform cannulation under ultrasound guidance, enabling us to insert the needles straight into the blood vessel. The NanoMaxx is particularly useful for diagnosing clotted or poorly flowing fistulas, and has dramatically reduced the number of problems and patients being referred back to the vascular access team. It has certainly made a big difference to the service."

For more information about SonoSite products, please contact:
SonoSite Ltd,
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP

T +44 (0)1462 444 800, F +44 (0)1462 444 801
ukresponse ( @ ) sonosite dot com www dot sonosite dot com

About SonoSite
SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.

###

space

Other Related Press Releases